Ha habido 50 transacciones internas recientes registradas para Fusion Pharmaceuticals Inc. (FUSN), incluyendo 32 compras y 14 ventas. El total de compras internas fue valorado en $1.35M y el total de ventas internas en $1.35M.
Internos destacados con actividad reciente incluyen Cagnoni Pablo J, Duncan Barbara Gayle, Leamon Christopher P. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — FUSN
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-06-04 |
Cagnoni Pablo J |
Director |
Devolución de Acciones |
141,011 |
$2.35 |
$331.38K |
- |
| 2024-06-04 |
Duncan Barbara Gayle |
Director |
Devolución de Acciones |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Leamon Christopher P |
Chief Scientific Officer |
Devolución de Acciones |
63,700 |
- |
- |
- |
| 2024-06-04 |
Meek David D. |
Director |
Devolución de Acciones |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-06-04 |
Crowley John J |
Chief Financial Officer |
Devolución de Acciones |
63,700 |
- |
- |
- |
| 2024-06-04 |
Gannon Steven |
Director |
Devolución de Acciones |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Bergstrom Donald A |
Director |
Devolución de Acciones |
34,000 |
$10.59 |
$360.06K |
- |
| 2024-06-04 |
Valliant John |
Chief Executive Officer |
Devolución de Acciones |
192,200 |
- |
- |
- |
| 2024-06-04 |
Burak Eric |
Chief Technology Officer |
Devolución de Acciones |
63,700 |
- |
- |
- |
| 2024-06-04 |
Lee Philina |
Director |
Devolución de Acciones |
17,000 |
$4.64 |
$78.88K |
- |
| 2024-06-04 |
Bender Jeremy |
Director |
Devolución de Acciones |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-06-04 |
Rawat Mohit |
President & Cbo |
Devolución de Acciones |
81,300 |
- |
- |
- |
| 2024-06-04 |
Bobilev Dmitri |
Chief Medical Officer |
Devolución de Acciones |
91,000 |
- |
- |
- |
| 2024-06-04 |
Bitetti Teresa Marie |
Director |
Devolución de Acciones |
34,000 |
$4.16 |
$141.44K |
- |
| 2024-01-04 |
Leamon Christopher P |
Chief Scientific Officer |
Concesión de RSU |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Crowley John J |
Chief Financial Officer |
Concesión de RSU |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Valliant John |
Chief Executive Officer |
Concesión de RSU |
192,200 |
- |
- |
192,200 |
| 2024-01-04 |
Burak Eric |
Chief Technology Officer |
Concesión de RSU |
63,700 |
- |
- |
63,700 |
| 2024-01-04 |
Rawat Mohit |
President & Cbo |
Concesión de RSU |
81,300 |
- |
- |
81,300 |
| 2024-01-04 |
Bobilev Dmitri |
Chief Medical Officer |
Concesión de RSU |
91,000 |
- |
- |
91,000 |
| 2023-10-16 |
Meek David D. |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-10-16 |
Meek David D. |
Director |
Concesión de RSU |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-10-16 |
Bender Jeremy |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-10-16 |
Bender Jeremy |
Director |
Concesión de RSU |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-10-16 |
Bitetti Teresa Marie |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-10-16 |
Bitetti Teresa Marie |
Director |
Concesión de RSU |
34,000 |
$4.16 |
$141.44K |
34,000 |
| 2023-08-31 |
Leamon Christopher P |
Chief Scientific Officer |
Concesión de RSU |
11,957 |
- |
- |
11,957 |
| 2023-08-31 |
Rawat Mohit |
President & Cbo |
Concesión de RSU |
12,843 |
- |
- |
12,843 |
| 2023-06-14 |
Cagnoni Pablo J |
Director |
Concesión de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Duncan Barbara Gayle |
Director |
Concesión de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Preston Heather |
Director |
Concesión de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Khuong Chau Quang |
Director |
Concesión de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Gannon Steven |
Director |
Concesión de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Bergstrom Donald A |
Director |
Concesión de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-06-14 |
Lee Philina |
Director |
Concesión de RSU |
17,000 |
$4.64 |
$78.88K |
17,000 |
| 2023-01-05 |
Leamon Christopher P |
Chief Scientific Officer |
Concesión de RSU |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Crowley John J |
Chief Financial Officer |
Concesión de RSU |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Valliant John |
Chief Executive Officer |
Concesión de RSU |
500,000 |
- |
- |
500,000 |
| 2023-01-05 |
Burak Eric |
Chief Technology Officer |
Concesión de RSU |
250,000 |
- |
- |
250,000 |
| 2023-01-05 |
Rawat Mohit |
President and Cbo |
Concesión de RSU |
300,000 |
- |
- |
300,000 |
| 2022-11-11 |
Khuong Chau Quang |
Director |
Concesión de RSU |
42,093 |
$2.38 |
$100.18K |
42,093 |
| 2022-11-07 |
Bobilev Dmitri |
Officer |
Desconocido |
- |
- |
- |
- |
| 2022-11-07 |
Bobilev Dmitri |
Chief Medical Officer |
Concesión de RSU |
550,000 |
- |
- |
550,000 |
| 2022-08-11 |
Gannon Steven |
Director |
Compra Informativa |
44,400 |
$2.03 |
$90.13K |
56,400 |
| 2022-06-14 |
Cagnoni Pablo J |
Director |
Concesión de RSU |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Duncan Barbara Gayle |
Director |
Concesión de RSU |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Preston Heather |
Director |
Concesión de RSU |
17,000 |
- |
- |
17,000 |
| 2022-06-14 |
Khuong Chau Quang |
Director |
Concesión de RSU |
17,000 |
$3.60 |
$61.2K |
17,000 |
| 2022-06-14 |
Gannon Steven |
Director |
Concesión de RSU |
17,000 |
$3.60 |
$61.2K |
17,000 |
| 2022-06-14 |
Bergstrom Donald A |
Director |
Concesión de RSU |
17,000 |
$3.60 |
$61.2K |
17,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento